Revise Notes Cardio Flashcards
Acs
Background
The term Acute coronary syndrome (ACS) encompasses a spectrum of myocardial ischaemic disease, including:
STEMI – Presence of classical ECG changes (ST elevation/ LBBB) and positive biochemical markers (troponins)
NSTEMI – Absence of ST elevation but positive biochemical markers +/- other ECG changes (such as T wave inversion)
Unstable angina – myocardial ischaemia without infarction - negative troponins, worsening angina symptoms including at rest/minimal exertion.
NICE Guidelines: Management of Unstable Angina and NSTEMI
Excellent NICE visual summary: https://www.nice.org.uk/guidance/ng185/resources/visual-summary-unstable-angina-nstemi-pdf-8900622109
The initial management steps of unstable angina (UA) and NSTEMI are generally the same. Certain interventions are then implemented on a risk basis.
Risk assessment
The most commonly used tool to assess a patient’s risk is the GRACE score.
The GRACE score formally assesses the risk of future cardiovascular events and 6-month mortality rate. Risk factors include:
Age, heart rate, systolic BP, creatinine
Cardiac enzymes, presence of ST elevation on ECG, cardiac arrest on admission
Killip class (signs of HF)
1. No evidence of HF
2. Crepitations / S3
3. Frank pulmonary oedema
4. Cardiogenic shock
Management ACS
Step 1: Antiplatelets
1st Antiplatelet - Give Aspirin 300mg loading, continue indefinitely
Dual antiplatelets: Depends on risk (GRACE) - see below
Acs mng
Step 2: Antithrombin
Thrombin is the enzyme which converts fibrinogen into fibrin - an integral step in clot formation.
There are 2 main antithrombin treatment options - fondaparinux or unfractioned heparin
- Fondaparinux
Offer fondaparinux to all patients, unless undergoing immediate coronary OR high risk of bleeding.
2. Unfractionated Heparin (UFH)
Indications for UFH:
Significant renal impairment – Creatinine > 265
High bleeding risk: CKD, old age, low body weight, relevant comorbidities
Acs mng
Step 3: Further Management - Conservative vs early invasive approach
Unstable condition
Offer immediate coronary angiography
Intermediate/high risk - GRACE > 3% - Early invasive approach:
Perform coronary angiography (+/- PCI) within 72 hours
Second antiplatelet:
Prasugrel or ticagrelor (with aspirin as DAPT)
OR clopidogrel (with aspirin as DAPT) if they have a separate indication for ongoing PO anticoagulation
Acs mng
Low risk - GRACE < 3% - Conservative approach
Consider functional imaging before discharge
If inducible ischaemia, proceed to coronary angiography +/- PCI
Second antiplatelet:
Offer ticagrelor (with aspirin as DAPT)
If high bleeding risk, use clopidogrel (with aspirin as DAPT) instead
NICE Guidelines: Management of STEMI
Diagnostic criteria: ST-elevation in 2 or more contiguous leads or new LBBB
Excellent NICE visual summary: https://www.nice.org.uk/guidance/ng185/resources/visual-summary-stemi-pdf-8900623405
Management of STEMI
- Antiplatelets
Single loading dose of aspirin 300mg
Second antiplatelet (DAPT) - Various options..
Having PCI
Prasugrel if not taking an oral anticoagulant
Or ticagrelor or clopidogrel if high bleeding risk
Clopidogrel if taking an oral anticoagulant
NOT having PCI - ticagrelor OR clopidogrel if high bleeding risk
- Coronary reperfusion therapy
Mng of stemi
Is primary PCI possible in < 120 minutes? AND presentation within 12 hours - YES
Primary PCI
Patients with STEMI should be offered angiography + PCI if they present within 12 hours of symptom onset and primary PCI can be performed within 2 hours.
Also consider if late presentation (>12hrs) but continuing ischaemia or shock.
Is primary PCI possible in < 120 minutes? NO
If PPCI is not possible in < 120 minutes, treat with fibrinolysis.
Fibrinolytic drugs: alteplase, streptokinase, tenecteplase or reteplase
Also give an antithrombin at the same time (fondaparinux/UFH)
Repeat ECG
Repeat ECG 60 – 90 minutes following fibrinolysis.
If there is residual ST elevation (>50%) - immediate coronary angiography + PCI.
Post-MI Complications
Secondary Prevention
All patients should be treated with the following:
Cardiac rehabilitation program
Dual antiplatelet therapy
Aspirin 75mg OD for life
Second antiplatelet depends on management - ticagrelor, clopidogrel etc.
In patients with other vascular disease (stroke/peripheral arterial disease), after one year of DAPT, clopidogrel (not aspirin) should be continued.
In patients who take a NOAC, use single antiplatelet therapy
ACE inhibitor (ARB if not tolerated)
Beta blocker
High dose statin
Aldosterone antagonist for HFrEF
Post-MI Complications
Ventricular Fibrillation - the most common cause of death post-MI
Arrhythmias – especially AV block in those following an inferior MI (RCA)
Pericarditis
Within 2-3 days – pain on lying flat, pericardial rub on auscultation, pericardial effusion on echo
Dressler’s syndrome
An autoimmune process. Differentiated from pericarditis by delayed onset
Occurs at 4-6 weeks – suggested by fever, pleuritic chest pain, raised ESR, pericardial effusion.
Manage with NSAIDs
Post-MI Complications
Left ventricular aneurysm
Suggested by persistent ST elevation and symptoms of left ventricular failure.
Treat with NOAC (reduce risk thrombosis)
LV free wall rupture
Occurs at 1-2 weeks
Presents with cardiac tamponade (Beck’s triad of acute HF, raised JVP, quiet heart sounds)
Management: Urgent pericardiocentesis and thoracotomy
Ventricular septal defect
1-2 weeks post MI
Harsh pansystolic murmur
Mitral regurgitation
Papillary muscle rupture - pansystolic murmur, heart failure and hypotension
Acute limb ischaemia
Key learning
Acute limb ischaemia: Rapid revascularization within 6 hours is crucial to prevent tissue necrosis.
Clinical features: 6Ps—pale, pulseless, painful, perishingly cold, paralysed, paraesthesia.
Investigations: If time allows then CT/MRI angiography to differentiate thrombosis from embolism.
Management:
Initial—ABCDE, high-flow oxygen, IV heparin, inform vascular team.
Operative—thrombolysis, angioplasty, embolectomy, or bypass.
Acute limb ischaemia
Pathophysiology
1) Thrombotic occlusion of diseased vessel
OR
2) Embolisation from a distant site
Acute limb ischaemia
Definitions
Acute
Previously stable limb with sudden deterioration in arterial supply in < 14 days
Acute on chronic
Worsening signs/symptoms over last 14 days
Chronic
Ischaemia stable for > 14 days
Critical limb ischaemia
Persistent rest pain or tissue loss (Fontaine Stage 3 or 4)
Acute limb ischemia causes
- Thrombosis
60%
Less severe as collateral vessels
- Embolism
30%
Cardiac origin- most common
AF
Mural thrombus post MI
Arterial origin
Aortic/femoral/popliteal aneurysm
Venous origin- rare
Patent foramen ovale
Iatrogenic
Post surgery/angioplasty
Cholesterol emboli
Following long bone fracture
Acute limb ischemia causes
- Trauma
Compression/dissection of artery or compartment syndrome (see separate section on compartment syndrome)
Most common sites:
Supracondylar humerus fracture
Posterior knee dislocation
Post-vascular surgery
Clinical features
6Ps
6Ps
Pale
Pulseless
Painful
Perishingly cold
Paralysed (later on)
Paraesthetic (later on)
Others:
Pain on passive movement of squeezing calf (later on and not part of 6Ps)
Non-viable limb signs:
Fixed mottling- Non-blanching colour changes in leg
Rigid muscles
Investigations acute limb ischemia
Pre-op:
Bloods:
Hb
Ischaemia worsened if anaemic
Clotting and G&S/X-match
As operative intervention likely
UEs
Acute ischaemic limb is associated with renal artery stenosis/ rhabdomyolysis
Glucose/lipids
Underlying cardiovascular risk factors
ABG
Lactate